Oral Ketamine (Neurocentrx Pharma)

N/A

Report date: 2023/12/26 18:02:50

Base Information

Drug NameOral Ketamine (Neurocentrx Pharma)
Drug Alias NameKeticapKeticap Oral CapsulesAD-KET-IR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantAnorexia NervosaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurocentrx Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNeurocentrx Pharma
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantAnorexia NervosaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A